52 withdrawn. 52 Phase 2, 7 Phase 1, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 52 | Withdrawn 52 |
| Phase 1 | 7 | Withdrawn 7 |
| Phase 3 | 6 | Withdrawn 6 |
Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy HDM sublingual Immunotherapy, Placebo - Asthma, Allergy | Phase 2 | Withdrawn | Boston Children's Hospital | 2027-02-01 | 2024-11-26 | |
| Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias fostamatinib - Immune Mediated Anemia, Immune Mediated Thrombocytopenia | Phase 2 | Withdrawn | National Heart, Lung, and Blood Institute (NHLBI) | 2025-11-07 | 2025-11-10 | |
| Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations Montelukast Oral Granules - Asthma; Status, Asthma in Children | Phase 2 | Withdrawn | Vanderbilt University Medical Center | 2025-09-01 | 2024-11-18 | |
| Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy Belumosudil - Chronic Graft Versus Host Disease | Phase 2 | Withdrawn | Kadmon, a Sanofi Company | 2025-06-16 | 2026-02-12 | |
| Terbutaline Sulfate in Adults With Asthma Terbutaline - Asthma | Phase 2 / Phase 3 | Withdrawn | Kanecia Obie Zimmerman | 2023-07-07 | 2026-01-22 | |
| Evaluating Effects of Curcumin in Moderate to Severe Asthmatics Curcumin, Placebo - Asthma | Phase 2 | Withdrawn | Loma Linda University | 2021-09-01 | 2021-11-17 | |
| Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis Magnesium Sulfate - Bronchiolitis, Viral | Phase 2 / Phase 3 | Withdrawn | University of Louisville | 2021-07-21 | 2026-05-11 | |
| Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation Anakinra, Anakinra Matching Placebo, Dermatophagoides Farinae - Asthma | Phase 1 / Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2020-09-01 | 2021-05-14 | |
| Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS) Assigned Interventions - Disorder Related to Lung Transplantation, Chronic Rejection of Lung Transplant | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2020-06-30 | 2023-05-06 | |
| A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen AZD8154 nebulizer suspension, 20 mg/mL, Placebo - Asthma | Phase 2 | Withdrawn | AstraZeneca | 2020-02-06 | 2020-11-03 | |
| Anakinra as a Rescue Treatment for Allergic Inflammation Anakinra, Preservative-free 0.9% sodium chloride (Placebo), House dust mite allergen - Asthma, Allergic | Phase 1 / Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2019-12-16 | 2022-06-08 | |
| Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy Microcannula Harvest Adipose, Centricyte 1000, IV Sterile Normal Saline - BPH, Nocturia | Phase 1 / Phase 2 | Withdrawn | Robert W. Alexander, MD, FICS | 2019-11-01 | 2021-01-12 | |
| Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. QAW039 - Asthma, Asthma, Bronchial | Phase 2 | Withdrawn | Novartis Pharmaceuticals | 2019-10-15 | 2020-05-14 | |
| Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation Anakinra, Anakinra Matching Placebo, Dermatophagoides Farinae - Asthma | Phase 1 / Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2019-08-09 | 2021-05-07 | |
| A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma GSK2245035, Placebo, FP-DPI - Asthma | Phase 2 | Withdrawn | GlaxoSmithKline | 2019-01-21 | 2018-10-16 | |
| Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments Nitazoxanide, Placebo (for Nitazoxanide) - Bronchiolitis | Phase 2 | Withdrawn | Telethon Kids Institute | 2016-12-01 | 2017-10-12 | |
| A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma Sirukumab, Placebo, Rescue medication - Asthma | Phase 2 | Withdrawn | GlaxoSmithKline | 2016-09-23 | 2018-08-31 | |
| CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids CYT003, Placebo - Asthma | Phase 2 | Withdrawn | Cytos Biotechnology AG | 2014-05-01 | 2014-05-14 | |
| Trial of Simvastatin for the Treatment of Severe Asthma Simvastatin, Placebo - Severe Asthma | Phase 2 | Withdrawn | University of California, Davis | 2013-12-01 | 2017-09-26 | |
| Treating Wheezing in Children With Hypertonic Saline (TWICS) hypertonic saline, saline - Wheeze | Phase 2 | Withdrawn | Dr. Michael Flavin | 2013-10-01 | 2015-11-13 |
Showing 20 of 52. Sign in to see all of them.
Asthma (41) · Bronchiolitis Obliterans Syndrome (7) · Bronchiolitis (3) · Respiratory Sounds (2) · Brain Injuries, Traumatic (1) · Bronchiolitis, Viral (1) · Bronchitis, Chronic (1) · Dyspnea (1) · Eosinophilia (1) · Graft vs Host Disease (1) · Hypersensitivity (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Lung Diseases, Obstructive (1) · Nocturia (1)
Lung Diseases (52) · Lung Diseases, Obstructive (51) · Respiratory Tract Diseases (51) · Immune System Diseases (48) · Hypersensitivity, Immediate (41) · Respiratory Hypersensitivity (41) · Hypersensitivity (40) · Bronchitis (12) · Bronchiolitis (8) · Bronchiolitis Obliterans (7) · Organizing Pneumonia (7) · Pathological Conditions, Signs and Symptoms (7) · Graft vs Host Disease (6) · Infections (5)
Antigens, Dermatophagoides (3) · Interleukin 1 Receptor Antagonist Protein (3) · montelukast (3) · Albuterol (2) · Allergens (2) · Magnesium Sulfate (2) · Receptors, Interleukin-6 (2) · Sodium Chloride (2) · 2-hydroxy-N,N-dimethyl-3-(2-((1-(5-methylfuran-2-yl)propyl)amino)-3,4-dioxocyclobut-1-enylamino)benzamide (1) · 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole (1) · Adalimumab (1) · Aging (1) · Beclomethasone (1) · CXA-10 (1) · CYT003-QbG10 (1)
Boehringer Ingelheim (4) · GlaxoSmithKline (4) · University of North Carolina, Chapel Hill (3) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Novartis Pharmaceuticals (2) · University of Chicago (2) · University of Louisville (2) · Abbott (1) · Acerus Pharmaceuticals Corporation (1) · AstraZeneca (1) · Boston Children's Hospital (1) · Bristol-Myers Squibb (1) · Centocor, Inc. (1) · Charles Cox (1) · Cytos Biotechnology AG (1)
United States (20) · Canada (2) · France (2) · Germany (2) · United Kingdom (2) · Australia (1) · Hungary (1) · Italy (1) · Netherlands (1) · Poland (1) · Russia (1) · Spain (1)
Michelle Hernandez, MD (2) · Aldo T Iacono, MD (1) · Beverly Paperiello (1) · Blanca Camoretti-Mercado, Ph.D. (1) · Charles S Cox, Jr., MD (1) · Daniel R Couriel, M.D. (1) · Donald H Arnold, MD, MPH (1) · James X Hartmann, PhD (1)
PMID 16407509, PMID 28639856, PMID 34404358
R01HL135235 (3), 2009 (2), 2008 (1), UL1RR024999 (1)